Brighton Jones’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15,356
Closed -$513K – 1501
2026
Q2
$513K Buy
+15,356
New +$381K 0.01% 778

Other funds holding RARE

Brighton Jones's RARE Position: Q3 2026 in Review

Brighton Jones sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2026, closing a stake of 15,356 shares — an estimated $513K sold.

Brighton Jones first reported a position in RARE in Q2 2026 and held it in 1 quarter. The position peaked at $513K in Q2 2026. 207 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Brighton Jones reported no remaining Ultragenyx Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 15,356 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $513K.
  • Brighton Jones first reported a position in Ultragenyx Pharmaceutical in Q2 2026 and held it in 1 quarter.
  • Brighton Jones's Ultragenyx Pharmaceutical position peaked at $513K in Q2 2026.
  • 207 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.